publication venue for
- Fetal and neonatal alloimmune thrombocytopenia: progress and ongoing debates.. 22. 2007
- AML and the art of remission maintenance. 2021
- Modern management of relapsed and refractory aggressive B-cell lymphoma: A perspective on the current treatment landscape and patient selection for CAR T-cell therapy. 2019
- Time to repeal and replace response criteria for acute myeloid leukemia? 2019
- Myeloid-derived suppressor cells: The green light for myeloma immune escape. 2016
- CML vaccines as a paradigm of the specific immunotherapy of cancer. 2000
- Immune deficiency/dysregulation -associated lymphoproliferative disorders. Revised classification and management. 2024
- Αlpha-thalassemia: A practical overview. 2024
- Paroxysmal nocturnal hemoglobinuria: Review of the patient experience and treatment landscape. 2023
- Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS). 2023
- Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS). 2023
- 'Secondary' acute lymphoblastic/lymphocytic leukemia - done playing second fiddle? 2023
- Taking the EZ way: Targeting enhancer of zeste homolog 2 in B-cell lymphomas. 2022
- Harnessing the power of sphingolipids: Prospects for acute myeloid leukemia. 2022
- Getting blood out of a stone: Identification and management of patients with poor hematopoietic cell mobilization. 2020
- The clinical implications of clonal hematopoiesis in hematopoietic cell transplantation. 2020
- JAKs to STATs: A tantalizing therapeutic target in acute myeloid leukemia. 2019
- HIV-related thrombocytopenia. 2002